These products are not intended to diagnose, treat, cure or prevent any disease
Suggested Titration Schedule Clinical Evidence & Research Behind Retatrutide Phase 2 clinical trials published in the New England Journal of Medicine demonstrated that Retatrutide produced superior weight loss compared to semaglutide and tirzepatide at equivalent timeframes
Create a poster or infographic tracking the transformation from Gila monster venom to Ozempic
Read more GLP-1 Medications May Reduce Depression and Anxiety: What the New Research Shows A major 2026 Lancet Psychiatry study of 100,000 people found GLP-1 medications reduced depression risk by 44% and anxiety by 38%
Understanding the Retatrutide vs Ozempic differences in dosing, access, and expectations will save you time and help set realistic goals
As the prevalence of diabetes is increasing globally, semaglutides durable GLP-1 action